GlobeImmune Inc.

1.3800-0.1300-8.61%Vol 5.30K1Y Perf 1 340.50%
Apr 20th, 2021 19:58
BID0.0000 ASK0.0000
Open1.2500 Previous Close1.5100
Pre-Market- After-Market-
 - -%  - -
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap7.94M 
Earnings Rating
Neutral
Price Range Ratio 52W %
24.27 
Earnings Date
6th Jul 2017

Today's Price Range

1.25001.3900

52W Range

0.07215.4600

5 Year PE Ratio Range

0.00000.0000

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-9.51%
1 Month
-38.67%
3 Months
278.08%
6 Months
711.76%
1 Year
1 340.50%
3 Years
220.93%
5 Years
-29.59%
10 Years
0.00%

TickerPriceChg.Chg.%
GBIM1.3800-0.1300-8.61
AAPL132.15-0.9600-0.72
GOOG2 263.38-30.2500-1.32
MSFT259.210.95000.37
XOM55.700.41000.74
WFC42.780.24000.56
JNJ165.73-0.7500-0.45
FB298.09-4.5600-1.51
GE13.220.16001.23
JPM149.510.24000.16
Earnings HistoryEstimateReportedSurprise %
Q01 2016--0.15-
Q04 2015--0.14-
Q03 2015--0.13-
Q02 2015--0.23-
Q01 2015--0.27-
Q03 2014--0.64-
Q02 2014--1.25-
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume5.30K
Shares Outstanding5.75M
Trades Count254
Dollar Volume411.86K
Avg. Volume46.90K
Avg. Weekly Volume8.84K
Avg. Monthly Volume17.78K
Avg. Quarterly Volume51.08K
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

GlobeImmune Inc.

GlobeImmune Inc is a US-based biopharmaceutical company which focuses on developing products for the treatment of cancer and infectious diseases based on its proprietary Tarmogen platform. It develops few Tarmogen product candidates for infectious disease and multiple cancer indications. The pipeline products of the company are GS-4774, GI-19000, GI-2010, GI-18000 which targets HBV and HIV antigens, TB antigens and Delta virus antigens and Oncology product candidates such as GI-6207, GI-6301, GI4000 which targets Carcinoembryonic antigen, Brachyury, and Mutated Ras.

CEO: Timothy C. Rodell

Telephone: +1 303 625-2700

Address: 1450 Infinite Drive, Louisville 80027, CO, USA

Number of employees: 2

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

57%43%

Bearish Bullish

48%52%

Bearish Bullish

50%50%

News